Definium Therapeutics, Inc. (DFTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Definium Therapeutics, Inc. (DFTX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

DFTX Cash Flow Statement

Definium Therapeutics, Inc. (DFTX) cash flow statement — 11-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-52.78M	-42.63M	-41.89M	-29.57M	-29.6M	-29.42M	-25.35M	-17.19M	-19.99M	-16.6M	-20.56M	-16.63M	-13.85M	-13.33M	-12.85M	-9.3M	-15.13M	-12.87M	-13.9M	-16.78M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-78.31%	-44.91%	-65.24%	-71.99%	-48.08%	-77.24%	-	-	-	-	-60.04%	-78.83%	8.47%	-3.61%	7.56%	44.6%	-35.41%	-33.74%	-94.63%	-189.15%
Net Income	-158.99M	-77.1M	-50.44M	-67.27M	-42.74M	-23.35M	-34.74M	-13.68M	-5.85M	-54.4M	-23.86M	-17.92M	-29.13M	-24.82M	-4.9M	-16.48M	-16.96M	-18.45M	-18.75M	-17.2M
Depreciation & Amortization	-631K	631K	0	6.75K	0	0	0	0	0	527K	790K	791K	790K	791K	790K	790K	820K	780K	-5.09M	789K
Stock-Based Compensation	9.64M	7.13M	11.42M	5.82M	5.25M	3.43M	3.44M	3.77M	5.43M	3.69M	3.68M	4.23M	3.84M	3.75M	1.38M	4.29M	4.25M	3.79M	11.04M	4.11M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	1.17M	0	0	0	0	0	-1.16M	0
Other Non-Cash Items	90.92M	21.26M	1.61M	23.78M	-197K	-7.04M	6.17M	-11.37M	-16.11M	34.26M	2.63M	-2.58M	14K	5.2M	-7.98M	1.51M	17K	-843K	1.23M	686K
Working Capital Changes	6.28M	5.45M	-4.48M	8.1M	8.09M	-2.46M	-225K	4.1M	-3.45M	-677K	-3.8M	-1.14M	9.47M	1.74M	-2.13M	599K	-3.26M	1.86M	-1.18M	-5.17M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-162K	1.78M	-2.85M	3.9M	1.95M	258K	-139K	-534K	-2.96M	1.51M	-3.51M	-931K	6.26M	209K	1.27M	100K	-2.59M	0	1.28M	0
Cash from Investing	-316.74M	42M	37.53M	15.41M	-39.54M	-162.46M	0	0	0	0	0	0	0	0	0	0	0	0	225K	-27K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	47K	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	178K	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	33.75M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-27K
Cash from Financing	762.27M	5.31M	246.62M	749K	19.65M	1M	3.81M	69.35M	10.79M	169.25M	2.59M	17.4M	1.27M	583K	416K	58.21M	590K	-166K	129K	820K
Debt Issued (Net)	0	0	-259.19K	447K	19.91M	0	984K	0	9.8M	-128K	-42K	14.2M	0	0	0	0	0	0	0	0
Equity Issued (Net)	808.63M	5.31M	246.36M	757.06K	117.06K	186K	-984K	75M	-416.58K	175.98M	2.59M	3.09M	1.27M	583K	730K	41.57M	0	-407K	1K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-407K	0	0
Other Financing	-46.36M	0	515.88K	-455.06K	-377K	816K	3.81M	-5.64M	1.4M	-6.61M	49K	114K	0	0	-314K	16.64M	590K	241K	128K	820K
Net Change in Cash	392.75M	4.68M	237.88M	-13.43M	-49.46M	-190.89M	-21.54M	52.15M	-9.2M	152.63M	-18M	804K	-12.51M	-12.73M	-12.38M	48.78M	-14.73M	-13.07M	-12.38M	-11.18M
Free Cash Flow	-52.78M	-42.63M	-41.89M	-29.57M	-29.6M	-29.42M	-25.35M	-17.19M	-19.99M	-16.6M	-20.56M	-16.63M	-13.85M	-13.33M	-12.85M	-9.3M	-15.13M	-12.87M	-13.85M	-16.78M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-78.31%	-44.91%	-65.24%	-71.99%	-48.08%	-77.24%	-	-	-	-	-60.04%	-78.83%	8.47%	-3.61%	7.25%	44.6%	-35.41%	-33.71%	-93.97%	-189.15%
FCF per Share	-0.48	-0.39	-0.47	-0.34	-0.35	-0.34	-0.30	-0.21	-0.28	-0.35	-0.51	-0.42	-0.36	-0.35	-0.34	-0.32	-0.54	-0.46	-0.49	-0.60
FCF Conversion (FCF/Net Income)	0.33x	0.55x	0.83x	0.44x	0.69x	1.26x	0.73x	1.26x	3.41x	0.31x	0.86x	0.93x	0.48x	0.54x	2.62x	0.56x	0.89x	0.70x	0.83x	0.98x
Interest Paid	0	0	0	1.46M	2.58M	602K	683K	0	439K	434K	0	100K	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0